Grégoire Courtine
Founder chez ONWARD MEDICAL N.V.
Fortune : 4 M $ au 31/03/2024
Profil
Dr. Grégoire Courtine is a Director, Chief Scientific & Marketing Officer at Onward Medical SA, a Director & Chief Scientific Officer at Onward Medical NV and a Professor at Swiss Federal Institute of Technology.
He is on the Board of Directors at Onward Medical SA, Onward Medical NV and Centre Hospitalier Universitaire Vaudois.
Dr. Courtine also served on the board at NeuroRestore.
He received his doctorate degree from the University of Pavia.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ONWARD MEDICAL N.V.
2,27% | 25/03/2024 | 786 072 ( 2,27% ) | 4 M $ | 31/03/2024 |
Postes actifs de Grégoire Courtine
| Sociétés | Poste | Début |
|---|---|---|
| ONWARD MEDICAL N.V. | Founder | 01/01/2014 |
Onward Medical SA
 Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | Founder | 01/12/2014 |
| Swiss Federal Institute of Technology | Corporate Officer/Principal | - |
Centre Hospitalier Universitaire Vaudois
 Centre Hospitalier Universitaire Vaudois Hospital/Nursing ManagementHealth Services Centre Hospitalier Universitaire Vaudois is a university hospital located in Lausanne, CH. The SwitzerlandUV is also a renowned center of medical education and research, collaborating with the Faculty of Biology and Medicine of the University of Lausanne and the Swiss Federal Institute of Technology in Lausanne (EPFL). It has 16 clinical and medico-technical departments and is known for its academic achievements in healthcare, research, and teaching. The vast campus in the lake region is home to these institutions. The CEO of the Swiss company is Nicolas Demartines. | Director/Board Member | - |
Anciens postes connus de Grégoire Courtine
| Sociétés | Poste | Fin |
|---|---|---|
NeuroRestore
 NeuroRestore Pharmaceuticals: MajorHealth Technology NeuroRestore is a platform of symptom-relieving drug candidates for disease states in which cognitive ability is impaired, such as Alzheimer's disease, sleep apnea, traumatic brain injury, and Parkinson's disease. NeuroRestore is based in Lausanne, Switzerland. The Swiss company stimulates specific signaling pathways in the central nervous system known as neurotrophins, which play a crucial role in the function of nerve cells. The most well-known neurotrophins are NGF (nerve growth factor) and BDNF (brain-derived neurotrophic factor). NeuroRestore's drug candidates enhance communication between nerve cells and improve cognitive ability. The private company's leading drug candidate, ACD856, has recently completed clinical phase I studies and demonstrated positive effects. | Director/Board Member | - |
Formation de Grégoire Courtine
| University of Pavia | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ONWARD MEDICAL N.V. | Commercial Services |
| Entreprise privées | 3 |
|---|---|
Centre Hospitalier Universitaire Vaudois
Centre Hospitalier Universitaire Vaudois Hospital/Nursing ManagementHealth Services Centre Hospitalier Universitaire Vaudois is a university hospital located in Lausanne, CH. The SwitzerlandUV is also a renowned center of medical education and research, collaborating with the Faculty of Biology and Medicine of the University of Lausanne and the Swiss Federal Institute of Technology in Lausanne (EPFL). It has 16 clinical and medico-technical departments and is known for its academic achievements in healthcare, research, and teaching. The vast campus in the lake region is home to these institutions. The CEO of the Swiss company is Nicolas Demartines. | Health Services |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | Health Technology |
NeuroRestore
NeuroRestore Pharmaceuticals: MajorHealth Technology NeuroRestore is a platform of symptom-relieving drug candidates for disease states in which cognitive ability is impaired, such as Alzheimer's disease, sleep apnea, traumatic brain injury, and Parkinson's disease. NeuroRestore is based in Lausanne, Switzerland. The Swiss company stimulates specific signaling pathways in the central nervous system known as neurotrophins, which play a crucial role in the function of nerve cells. The most well-known neurotrophins are NGF (nerve growth factor) and BDNF (brain-derived neurotrophic factor). NeuroRestore's drug candidates enhance communication between nerve cells and improve cognitive ability. The private company's leading drug candidate, ACD856, has recently completed clinical phase I studies and demonstrated positive effects. | Health Technology |
